CRYM
Cryomass Technologies Inc. [CRYM] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CRYM Stock Summary
Top 10 Correlated Stocks
CRYM
In the News
CRYM Financial details
Company Rating
Sell
Market Cap
7.98M
Income
-15.15M
Revenue
932.84K
Book val./share
-0.02
Cash/share
0
Dividend
-
Dividend %
-
Employees
6
Optionable
No
Shortable
Yes
Earnings
15 May 2024
P/E
-0.68
Forward P/E
-
PEG
0.3
P/S
11.16
P/B
-3.01
P/C
-
P/FCF
-2.35
Quick Ratio
-
Current Ratio
0.11
Debt / Equity
-0.78
LT Debt / Equity
-0.71
-
-
EPS (TTM)
-0.07
EPS next Y
-
EPS next Q
-
EPS this Y
-45.65%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-77.42%
-
-
-
-
SMA20
-
SMA50
-20%
SMA100
-42.86%
Inst Own
-
Inst Trans
-
ROA
-1413%
ROE
-3892%
ROC
16.19%
Gross Margin
50%
Oper. Margin
-1575%
Profit Margin
-1624%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0211-0.1799
52W High
-
52W Low
-
RSI
47.56
Rel Volume
0.22
Avg Volume
125.23K
Volume
27.68K
Perf Week
7.32%
Perf Month
-20.95%
Perf Quarter
-57.62%
Perf Half Y
-54.91%
-
-
-
-
Beta
0.122
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0381
Change
-4.51%
CRYM Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.01 | -0.03 | -0.07 | -0.1 | -0.05 | |
| Operating cash flow per share | -0.01 | -0.02 | -0.04 | -0.04 | -0.02 | |
| Free cash flow per share | -0.01 | -0.02 | -0.04 | -0.04 | -0.03 | |
| Cash per share | 0 | 0.04 | 0 | 0.04 | 0.01 | |
| Book value per share | 0.01 | 0.14 | 0.04 | 0.09 | 0.02 | |
| Tangible book value per share | 0.01 | 0.06 | 0.04 | 0.05 | 0 | |
| Share holders equity per share | 0.01 | 0.14 | 0.04 | 0.09 | 0.02 | |
| Interest debt per share | 0 | 0.02 | 0.01 | 0.02 | 0.01 | |
| Market cap | 734.32K | 57.48M | 19.87M | 42.53M | 37.18M | |
| Enterprise value | 527.01K | 55.55M | 20.01M | 36.93M | 37.17M | |
| P/E ratio | -1.72 | -18.94 | -2.89 | -2.83 | -3.57 | |
| Price to sales ratio | 0 | 3.15M | 25.43K | 0 | 0 | |
| POCF ratio | -1.62 | -32.02 | -5.3 | -7.59 | -7.8 | |
| PFCF ratio | -0.81 | -31.35 | -5.3 | -7.3 | -7.2 | |
| P/B Ratio | 1.14 | 4.62 | 5.51 | 3.14 | 8.13 | |
| PTB ratio | 1.14 | 4.62 | 5.51 | 3.14 | 8.13 | |
| EV to sales | 0 | 3.04M | 25.6K | 0 | 0 | |
| Enterprise value over EBITDA | -1.56 | -19.35 | -3.06 | -4.65 | -3.66 | |
| EV to operating cash flow | -1.16 | -30.94 | -5.34 | -6.59 | -7.8 | |
| EV to free cash flow | -0.58 | -30.31 | -5.34 | -6.34 | -7.19 | |
| Earnings yield | -0.58 | -0.05 | -0.35 | -0.35 | -0.28 | |
| Free cash flow yield | -1.24 | -0.03 | -0.19 | -0.14 | -0.14 | |
| Debt to equity | 0 | 0.12 | 0.13 | 0.01 | 0.44 | |
| Debt to assets | 0 | 0.1 | 0.06 | 0.01 | 0.25 | |
| Net debt to EBITDA | 0.62 | 0.67 | -0.02 | 0.7 | 0 | |
| Current ratio | 4.32 | 2.52 | 1.89 | 3.47 | 1.68 | |
| Interest coverage | -8.56 | -237.78 | -27.58 | -3.65 | -70.14 | |
| Income quality | 1.06 | 0.59 | 0.55 | 0.55 | 0.46 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 166.11K | 8.39K | 0 | 0 | |
| Research and developement to revenue | 0 | 26.17K | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0.54 | 0 | 0.34 | 0.66 | |
| Capex to operating cash flow | 1.01 | 0.02 | 0 | 0.04 | 0.08 | |
| Capex to revenue | 0 | -2.07K | 0 | 0 | 0 | |
| Capex to depreciation | -623.8 | -0.26 | 0 | -5.15 | -2.55 | |
| Stock based compensation to revenue | 0 | 8.26K | 1.84K | 0 | 0 | |
| Graham number | 0.03 | 0.32 | 0.24 | 0.43 | 0.16 | |
| ROIC | -0.46 | -0.2 | -1.61 | -0.87 | -1.57 | |
| Return on tangible assets | -0.61 | -0.41 | -0.88 | -1.45 | -3.87 | |
| Graham Net | 0 | 0.01 | -0.03 | 0.02 | -0.01 | |
| Working capital | 189.17K | 2.37M | 3.67M | 4.65M | 878.03K | |
| Tangible asset value | 646.53K | 5.01M | 3.61M | 8.3M | -596.11K | |
| Net current asset value | 189.17K | 1.6M | 3.61M | 4.47M | -1.12M | |
| Invested capital | 0 | 0.12 | 0.13 | 0.01 | 0.44 | |
| Average receivables | 0 | 0 | 270K | 270K | 0 | |
| Average payables | 85.92K | 402.02K | 1.5M | 2.06M | 1.59M | |
| Average inventory | 5.23K | 175.23K | 170K | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 252.22K | 0 | 0 | |
| Days payables outstanding | 0 | 1.39M | 1.1M | 15.73K | 2.9K | |
| Days of inventory on hand | 0 | 624.18K | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0.02 | 0.13 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -0.66 | -0.24 | -1.91 | -1.11 | -2.28 | |
| Capex per share | -0.01 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.01 | -0.03 | -0.01 | -0.03 | -0.01 | |
| Operating cash flow per share | 0 | 0 | -0.01 | 0 | 0 | |
| Free cash flow per share | 0 | -0.01 | -0.01 | -0.01 | 0 | |
| Cash per share | 0.02 | 0.01 | 0 | 0 | 0 | |
| Book value per share | 0.05 | 0.02 | 0.02 | -0.01 | -0.02 | |
| Tangible book value per share | 0.02 | 0 | -0.01 | -0.01 | -0.02 | |
| Share holders equity per share | 0.05 | 0.02 | 0.02 | -0.01 | -0.02 | |
| Interest debt per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Market cap | 47.49M | 37.51M | 28.56M | 28.71M | 19.23M | |
| Enterprise value | 46.36M | 37.49M | 29.9M | 30.92M | 21.88M | |
| P/E ratio | -9.87 | -1.67 | -4.15 | -1.13 | -3.31 | |
| Price to sales ratio | 0 | 40.21 | 0 | 0 | 0 | |
| POCF ratio | -53.66 | -41.06 | -21.34 | -28.74 | -21.99 | |
| PFCF ratio | -51.69 | -33.03 | -21.13 | -27.75 | -21.38 | |
| P/B Ratio | 4.84 | 8.2 | 9.05 | -10.42 | -5.63 | |
| PTB ratio | 4.84 | 8.2 | 9.05 | -10.42 | -5.63 | |
| EV to sales | 0 | 40.19 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -37.63 | -6.92 | -21.25 | -24.02 | -16.29 | |
| EV to operating cash flow | -52.39 | -41.05 | -22.34 | -30.95 | -25.02 | |
| EV to free cash flow | -50.46 | -33.02 | -22.11 | -29.88 | -24.32 | |
| Earnings yield | -0.03 | -0.15 | -0.06 | -0.22 | -0.08 | |
| Free cash flow yield | -0.02 | -0.03 | -0.05 | -0.04 | -0.05 | |
| Debt to equity | 0.2 | 0.44 | 0.63 | -0.92 | -0.78 | |
| Debt to assets | 0.15 | 0.25 | 0.3 | 1.86 | 2.48 | |
| Net debt to EBITDA | 0.92 | 0 | -0.95 | -1.71 | -1.97 | |
| Current ratio | 2.64 | 1.68 | 0.54 | 0.26 | 0.11 | |
| Interest coverage | -63.85 | -98.25 | -28.54 | -75.96 | -12.56 | |
| Income quality | 0.72 | 0.16 | 0.84 | 0.16 | 0.6 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 5.81 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0.02 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.4 | 0.66 | 0.77 | 0.1 | 0.11 | |
| Capex to operating cash flow | 0.04 | 0.24 | 0.01 | 0.04 | 0.03 | |
| Capex to revenue | 0 | -0.24 | 0 | 0 | 0 | |
| Capex to depreciation | -1.55 | -2.43 | -0.11 | -0.25 | -0.83 | |
| Stock based compensation to revenue | 0 | 0.33 | 0 | 0 | 0 | |
| Graham number | 0.08 | 0.12 | 0.05 | 0.1 | 0.05 | |
| ROIC | -0.1 | -0.84 | -0.32 | 27.37 | 1.95 | |
| Return on tangible assets | -0.15 | -2.08 | -1.13 | -5.18 | -1.52 | |
| Graham Net | 0 | -0.01 | -0.01 | -0.02 | -0.02 | |
| Working capital | 2.03M | 878.03K | -652.68K | -1.34M | -1.76M | |
| Tangible asset value | 4.6M | -596.11K | -1.92M | -2.89M | -3.53M | |
| Net current asset value | 31.37K | -1.12M | -2.65M | -3.63M | -4.27M | |
| Invested capital | 0.2 | 0.44 | 0.63 | -0.92 | -0.78 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 1.16M | 1.26M | 1.36M | 1.51M | 1.66M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 5.09K | 248.62 | 1.03K | 992.06 | 5.16K | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0.02 | 0.36 | 0.09 | 0.09 | 0.02 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -0.12 | -1.23 | -0.54 | 2.31 | 0.43 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
CRYM Frequently Asked Questions
What is Cryomass Technologies Inc. stock symbol ?
Cryomass Technologies Inc. is a US stock , located in Denver of Co and trading under the symbol CRYM
What is Cryomass Technologies Inc. stock quote today ?
Cryomass Technologies Inc. stock price is $0.0381 today.
Is Cryomass Technologies Inc. stock public?
Yes, Cryomass Technologies Inc. is a publicly traded company.
Company Profile
- Volume Average 125.23K
- Market Capitalization 7.98M
- Employee 6
- CEO Mr. Christian Noel
- Headquarters Denver,CO,US
- IPO Date 2014-06-02
-
Website
https://cryomass.com 
Cryomass Technologies Inc. designs, sells, and commercializes cryo-mechanical system for the handling of harvested hemp, cannabis, and other high-value plants. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado.
